Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography
about
Development of New Deoxycytidine Kinase Inhibitors and Noninvasive in Vivo Evaluation Using Positron Emission TomographyELIXYS - a fully automated, three-reactor high-pressure radiosynthesizer for development and routine production of diverse PET tracers.Requirement for deoxycytidine kinase in T and B lymphocyte development.PET probes for distinct metabolic pathways have different cell specificities during immune responses in miceINDs for PET molecular imaging probes-approach by an academic institutionFast metabolic response to drug intervention through analysis on a miniaturized, highly integrated molecular imaging systemDeoxycytidine kinase augments ATM-Mediated DNA repair and contributes to radiation resistanceHuman biodistribution and radiation dosimetry of novel PET probes targeting the deoxyribonucleoside salvage pathwayNovel PET probes specific for deoxycytidine kinase.Plug-and-play modules for flexible radiosynthesis.Stratification of nucleoside analog chemotherapy using 1-(2'-deoxy-2'-18F-fluoro-β-D-arabinofuranosyl)cytosine and 1-(2'-deoxy-2'-18F-fluoro-β-L-arabinofuranosyl)-5-methylcytosine PET.Metabolomics strategy reveals subpopulation of liposarcomas sensitive to gemcitabine treatment.[18F]CFA as a clinically translatable probe for PET imaging of deoxycytidine kinase activity.Visualizing cancer and immune cell function with metabolic positron emission tomography.Radiochemical synthesis of 2'-[18F]-labelled and 3'-[18F]-labelled nucleosides for positron emission tomography imaging.Advances in PET Detection of the Antitumor T Cell Response.PET imaging of DNA damage using (89)Zr-labelled anti-γH2AX-TAT immunoconjugates.Synthesis and cytostatic evaluation of 4-N-alkanoyl and 4-N-alkyl gemcitabine analogues.Evaluation of the Genisys4, a bench-top preclinical PET scannerProteome-wide Profiling of Clinical PARP Inhibitors Reveals Compound-Specific Secondary Targets.A microreactor with phase-change microvalves for batch chemical synthesis at high temperatures and pressures.Detection of immune responses after immunotherapy in glioblastoma using PET and MRI.In Vitro and In Vivo Comparison of Gemcitabine and the Gemcitabine Analog 1-(2'-deoxy-2'-fluoroarabinofuranosyl) Cytosine (FAC) in Human Orthotopic and Genetically Modified Mouse Pancreatic Cancer Models.Imaging Cancer Metabolism.The NCI Alliance for Nanotechnology in Cancer: achievement and path forward.The 4-N-acyl and 4-N-alkyl gemcitabine analogues with silicon-fluoride-acceptor: Application to 18F-Radiolabeling.18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET).A novel radiochemical approach to 1-(2'-deoxy-2'-[(18) F]fluoro-β-d-arabinofuranosyl)cytosine ((18) F-FAC).TMSOTf assisted synthesis of 2'-deoxy-2'-[18F]fluoro-β-D-arabinofuranosylcytosine ([18F]FAC).Translational molecular imaging in exocrine pancreatic cancer
P2860
Q27679693-2379D991-70CE-406A-8A41-7E17C2EC83E2Q30541618-9ABAF3EA-0118-4242-849C-8D28587D029AQ33777990-1B3EC9E0-D679-415E-9525-85A97C8BD225Q33881305-76979C37-0DCF-4146-ABB1-D9219275D385Q33898974-B1BDDAD5-0A86-4ECC-A1B6-E0E57C69A681Q33931793-50983E6C-1F28-469A-B24A-2A458A1AC47AQ34015533-BFE33F1F-06B1-4433-8EDF-9CC957E84045Q34648037-D3526A89-B913-4ED1-9C7B-FD13156F4D16Q35059531-6D6ABDEA-7DDB-4B7D-AE16-0E6072A7003FQ35820696-767C87A5-146E-48F2-9DF1-6E0779CA7979Q36201693-AF13AF9B-5EFA-4A68-8E84-2C485236765CQ36493132-B3844961-287E-4650-8DFD-367D99B04E46Q36821582-55E20861-BA08-45B3-9AD4-F81443D18A43Q37237613-22D8FA5B-5B5A-4B54-A0A2-B2264BA2831AQ38201376-D903517F-F911-4A24-A79A-D36F6D3966BDQ38846891-5D40BA9B-70BB-418C-9A55-430661734065Q38868860-F5BB9E3E-90E1-4645-81FC-B822F6AF6A79Q39042999-B11A40D3-D1ED-4144-82ED-DB179D4450BBQ39158593-78135999-62AF-4DF4-B6CC-A19FF1EAD672Q40465701-5BA40ABC-7E2A-491E-9D33-6A2112137BA6Q43762629-0F965F2E-15B3-454E-87C6-536CCC4227D9Q46860353-B1994835-58EC-49C5-9471-E8E5A7B5ACECQ47109380-2E0CE1D8-0934-418B-9028-A6D3053C8493Q47117264-2CBB0661-7664-4441-8E74-217C6F7EE13AQ51766813-56C5F8D3-7767-4D84-8071-A70EF895EBCDQ52931150-AE221590-A6F4-40FF-AF50-10E8C5CE7138Q53042946-1C43BFA1-9509-4B21-A633-7A795E9F855CQ53258169-D6A761DB-2BED-4FDF-B3D1-E8735E8290A6Q54979953-6352BBB5-9774-41AC-B98B-7DB65C7AE0EDQ58728351-62F280C0-F564-4D69-8850-99851CD688B2
P2860
Noninvasive prediction of tumor responses to gemcitabine using positron emission tomography
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Noninvasive prediction of tumo ...... g positron emission tomography
@en
Noninvasive prediction of tumo ...... positron emission tomography.
@nl
type
label
Noninvasive prediction of tumo ...... g positron emission tomography
@en
Noninvasive prediction of tumo ...... positron emission tomography.
@nl
prefLabel
Noninvasive prediction of tumo ...... g positron emission tomography
@en
Noninvasive prediction of tumo ...... positron emission tomography.
@nl
P2093
P2860
P356
P1476
Noninvasive prediction of tumo ...... g positron emission tomography
@en
P2093
Caius G Radu
Dean O Campbell
Harvey R Herschman
Johannes Czernin
Martin A Walter
Michael E Phelps
Nagichettiar Satyamurthy
Owen N Witte
Rachel E Laing
P2860
P304
P356
10.1073/PNAS.0812890106
P407
P577
2009-02-05T00:00:00Z